Evoke Pharma, Inc. (EVOK) reported Loss for first quarter that decreased from the same period last year but missed the Street estimates.
The company's bottom line came in at -$1.31 million, or -$0.51 per share. This compares with -$1.58 million, or -$2.09 per share, last year.
Analysts on average had expected the company to earn -$0.33 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 77.5% to $3.080 million from $1.735 million last year.
Evoke Pharma, Inc. earnings at a glance (GAAP) :
-Earnings: -$1.31 Mln. vs. -$1.58 Mln. last year.
-EPS: -$0.51 vs. -$2.09 last year.
-Revenue: $3.080 Mln vs. $1.735 Mln last year.
For comments and feedback: editorial@rttnews.com